Transforming growth factor-beta stimulates collagen VII expression by cutaneous cells in vitro
about
Phenotypic spectrum of epidermolysis bullosa associated with α6β4 integrin mutationsThree novel homozygous point mutations and a new polymorphism in the COL17A1 gene: relation to biological and clinical phenotypes of junctional epidermolysis bullosaProteinases of the bone morphogenetic protein-1 family convert procollagen VII to mature anchoring fibril collagenTwo forms of collagen XVII in keratinocytes. A full-length transmembrane protein and a soluble ectodomainSome, but not all, glycine substitution mutations in COL7A1 result in intracellular accumulation of collagen VII, loss of anchoring fibrils, and skin blistering.Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrityElevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-betaSkin equivalent tissue-engineered construct: co-cultured fibroblasts/ keratinocytes on 3D matrices of sericin hope cocoons.Pathogenesis of mechanobullous disorders.Bioengineering a human plasma-based epidermal substitute with efficient grafting capacity and high content in clonogenic cellsExpression of epithelial adhesion proteins and integrins in chronic inflammationImmunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain.The role of fibroblasts in tissue engineering and regeneration.Epidermolysis bullosa: pathogenetic pathways from mutations to symptoms.TGF beta promotes the basal phenotype of epidermal keratinocytes: transcriptional induction of K#5 and K#14 keratin genes.Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing.Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa.
P2860
Q24336135-FF54EED5-D43F-486D-BC12-2CB544791750Q24676917-093CCC66-655E-44FC-BED2-C8E99C4B7798Q28216359-D0779EFC-FA42-4E45-87DC-F08A6BFE2D15Q28283395-F37EA6F2-4EF9-4E44-83C6-B04B4A914680Q32052839-30CAC547-76A1-4C10-847E-45F5854556D0Q33713926-15082DD6-9B53-4D29-8C20-5817BBD4FE99Q34140802-D6D79867-7BD5-4EED-9330-925F408EF66AQ34994893-03687094-906D-4962-A1B6-BAA71492E2BBQ35281718-E8FD8C9A-B01A-467C-8AA5-7D5E71D96D66Q35665288-11F9DB19-3461-4405-93F5-1457E9F31A08Q35796354-C8F03462-BF0D-43E9-9FAD-BC9F2330A348Q36382726-FA96EB5E-6A54-4CC7-8A7A-DB874C4ED803Q36834374-BA5DEB3F-50A6-4FF2-B7C7-38D73E8875F4Q40392062-18599FA3-5C1C-4BD4-96F9-DB1FD057FA2EQ42519294-99640329-0EC9-49C7-A22A-32EE95808F25Q42771319-DB2D8CBB-8099-4C4C-BD51-6B74FBC3BE62Q53770761-E22ADA43-B7A2-4A81-8A87-30A8537EA84E
P2860
Transforming growth factor-beta stimulates collagen VII expression by cutaneous cells in vitro
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Transforming growth factor-bet ...... on by cutaneous cells in vitro
@ast
Transforming growth factor-bet ...... on by cutaneous cells in vitro
@en
type
label
Transforming growth factor-bet ...... on by cutaneous cells in vitro
@ast
Transforming growth factor-bet ...... on by cutaneous cells in vitro
@en
prefLabel
Transforming growth factor-bet ...... on by cutaneous cells in vitro
@ast
Transforming growth factor-bet ...... on by cutaneous cells in vitro
@en
P2860
P356
P1476
Transforming growth factor-bet ...... on by cutaneous cells in vitro
@en
P2093
Bruckner-Tuderman L
P2860
P304
P356
10.1083/JCB.117.3.679
P407
P577
1992-05-01T00:00:00Z